Article
Germline Mutation in 1338 BRCA-Negative Chinese Hereditary Breast and/or Ovarian Cancer Patients: Clinical Testing with a Multigene Test Panel.
The Journal of molecular diagnostics : JMD - 1 Apr 2020
Kwong Ava, Shin Vivian Y, Chen Jiawei, Cheuk Isabella W Y, Ho Cecilia Y S, Au Chun H, Chan Karen K L, Ngan Hextan Y S, Chan Tsun L, Ford James M, Ma Edmond S K
Abstract excerpt
Differences in the mutation spectrum across ethnicities suggest the importance of identifying genes in addition to common high penetrant genes to estimate the associated breast cancer risk in China. A total of 1338 high-risk breast cancer patients who tested negative for germline BRCA1, BRCA2, TP53, and PTEN mutations between 2007 and 2017 were selected from the Hong Kong Hereditary Breast Cancer Family Registry....
Topics
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Alleles
- BRCA1 Protein
- BRCA2 Protein
- Biomarkers, Tumor
- Computational Biology
- Female
